Spirooxindoles as novel 3D-fragment scaffolds: Synthesis and screening against CYP121 from M. tuberculosis.

Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors.

CHAPTER 8 Fragment-Based Discovery of Antibacterials

ChemInform Abstract: Regioselective Conversion of Arenes to N‐Aryl‐1,2,3‐triazoles Using C—H Borylation.

Understanding "on-water" catalysis of organic reactions. Effects of H+ and Li+ ions in the aqueous phase and nonreacting competitor H-bond acceptors in the organic phase: On H2O versus on D2O for Huisgen cycloadditions

Natural product-inspired fragment-based drug discovery: Development of M. tuberculosis CYP121 inhibitors

Fragment-based drug discovery of potent and selective CYP121 inhibitors for tuberculosis

Small-molecule inhibitors that target protein-protein interactions in the RAD51 family of recombinases

Regioselective Conversion of Arenes to N‐aryl‐1,2,3‐triazoles Using CH Borylation

Overcoming the limitations of fragment merging: Rescuing a strained merged fragment series targeting mycobacterium tuberculosis CYP121